Casana vs Noom

Side-by-side comparison of AI visibility scores, market position, and capabilities

Noom leads in AI visibility (86 vs 36)
Casana logo

Casana

EmergingHealthcare

Remote Patient Monitoring Devices

Casana's Heart Seat received FDA 510(k) clearance for heart rate and SpO2 monitoring; raised $44M total; awaiting additional clearance for cuffless blood pressure before commercial launch.

AI VisibilityBeta
Overall Score
D36
Category Rank
#520 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
33
Gemini
34

About

Casana is a Rochester, New York-based medical device company developing the Heart Seat, a smart toilet seat designed to passively monitor cardiovascular health indicators for patients managing heart failure, hypertension, and other cardiac conditions at home. The device replaces a standard toilet seat and captures heart rate, blood oxygen saturation (SpO2), and is being developed to also monitor cuffless blood pressure — all without requiring the patient to take any conscious action. This passive monitoring model addresses a critical compliance gap in remote patient monitoring, where traditional wearables and cuffs require patient participation that many elderly or chronically ill patients cannot sustain.

Full profile
Noom logo

Noom

GrowthHealthcare

Weight Health Platform

Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.

AI VisibilityBeta
Overall Score
A86
Category Rank
#12 of 596
AI Consensus
67%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
81
Gemini
92

About

Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.

Full profile

AI Visibility Head-to-Head

36
Overall Score
86
#520
Category Rank
#12
79
AI Consensus
67
stable
Trend
stable
39
ChatGPT
80
33
Perplexity
81
34
Gemini
92
32
Claude
90
30
Grok
83

Key Details

Category
Remote Patient Monitoring Devices
Weight Health Platform
Tier
Emerging
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Noom
Weight Health Platform

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.